Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 1

1(12.5%)

8Total

N/A(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04730869Not ApplicableCompleted

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Role: lead

NCT07115420Not ApplicableNot Yet Recruiting

Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent

Role: lead

NCT05396950Not ApplicableNot Yet Recruiting

CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR

Role: lead

NCT06162468Not ApplicableNot Yet Recruiting

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Role: collaborator

NCT06137404Not ApplicableEnrolling By Invitation

A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger

Role: lead

NCT04952129Phase 1Completed

Optimal Selenium for Bowel Polyps (OSCAR)

Role: collaborator

NCT00745043Not ApplicableCompleted

Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) Study

Role: lead

NCT03503357Not ApplicableCompleted

ConsCIOUS2 Study of the Isolated Forearm Technique Commands

Role: collaborator

All 8 trials loaded